Ra Capital Management, L.P. Gh Research PLC Transaction History

Ra Capital Management, L.P.

$6.17 Billion
Q4 2024

A detailed history of Ra Capital Management, L.P. transactions in Gh Research PLC stock. As of the latest transaction made, Ra Capital Management, L.P. holds 6,686,689 shares of GHRS stock, worth $73.4 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares

6,686,689

Previous 6,686,689 -0.0%

Holding current value

$73.4 Million

Previous $44.7 Million 4.63%

% of portfolio

0.76%

Previous 0.62%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$6.69 - $12.49 $568,650 - $1.06 Million	85,000 Added 1.29%	6,686,689 $44.7 Million
Q2 2024 Aug 14, 2024	BUY	$10.5 - $14.81 $69.3 Million - $97.8 Million	6,601,689 New	6,601,689 $77 Million
Q1 2024 May 15, 2024	BUY	$5.34 - $11.09 $3.55 Million - $7.37 Million	664,381 Added 11.89%	6,251,714 $66.6 Million
Q4 2023 Feb 14, 2024	BUY	$5.26 - $11.04 $29.4 Million - $61.7 Million	5,587,333 New	5,587,333 $32.4 Million
Q2 2023 Aug 14, 2023	BUY	$7.88 - $12.74 $48,635 - $78,631	6,172 Added 0.11%	5,587,333 $66.3 Million
Q1 2023 May 15, 2023	BUY	$6.02 - $10.92 $4.11 Million - $7.46 Million	682,788 Added 13.94%	5,581,161 $44.6 Million
Q2 2022 Aug 15, 2022	BUY	$8.99 - $19.87 $638,676 - $1.41 Million	71,043 Added 1.47%	4,898,373 $48.9 Million
Q1 2022 May 16, 2022	BUY	$15.48 - $23.98 $30.7 Million - $47.6 Million	1,983,573 Added 69.75%	4,827,330 $88.3 Million
Q4 2021 Feb 14, 2022	SELL	$14.1 - $27.9 $2.4 Million - $4.75 Million	-170,200 Reduced 5.65%	2,843,757 $66.3 Million
Q3 2021 Nov 15, 2021	BUY	$16.51 - $23.68 $577,883 - $828,847	35,002 Added 1.17%	3,013,957 $66.5 Million
Q2 2021 Aug 16, 2021	BUY	$19.25 - $21.73 $57.3 Million - $64.7 Million	2,978,955 New	2,978,955 $64.7 Million

Others Institutions Holding GHRS

# of Institutions

Shares Held

28.3M

Call Options Held

10.3K

Put Options Held

3.7K

View Full List

About GH Research PLC

Ticker GHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,020,800
Market Cap $571M
Description
GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...

More about GHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ra Capital Management, L.P. with notifications on news.

Account

Ra Capital Management, L.P. Gh Research PLC Transaction History